In addition, we showed for the first time that oncolytic virotherapy led to a reduction of tumor cell-derived VEGF-levels, to decreased invasion of tumor cells into the peritumoral tissue, and to viral infection of blood vessel-invading tumor cells, thereby preventing formation of ME. The gene discussed is VEGFA; the disease is neoplasm.